Events
“Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?”
The European Union funds research on the pandemic threats of Dengue (DENV) and West Nile Virus (WNV)
Strengthening the EU's capacity to combat DENV and WNV epidemics and pandemic threats is necessary to develop effective contingency plans. For this reason, the EU has funded the international project InFlaMe (Grant Agreement ID: 101191725), which is based on three pillars: 1) the clinical investigation of factors related to serious disease 2) the development of [...]
CheckmAb’s Immunotherapy in Collaboration with Boehringer Ingelheim Advances to Next Stage
CheckmAb’s Immunotherapy in Collaboration with Boehringer Ingelheim Advances to Next Stage Milan, Italy, February 4th 2025 CheckmAb S.r.l. announced today the successful achievement of the second milestone in the collaboration with Boehringer Ingelheim for the development of a monoclonal antibody (mAb) for cancer immunotherapy. Cancer immunotherapies have delivered meaningful therapeutic options to some cancer patients, [...]
EU funds research into causes and new therapies for multiple sclerosis
EU funds research into causes and new therapies for multiple sclerosis The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible. It is now established that Epstein-Barr virus is involved in the development of MS. However, it is not known how the pathogen triggers the [...]
“The junk DNA” is able to activate immune response of T lymphocytes, the guards of the fight against cancer”
The research, coordinated by Beatrice Bodega and Sergio Abrignani, has identified for the first time a new mechanism involving RNA molecules deriving from "repeated elements" of DNA: until a few years ago considered "junk DNA", they are instead fundamental for the correct function of T lymphocytes, cells at the forefront of the fight against cancer. [...]
Antios Therapeutics Announces Agreement with IRBM, INGM and OSR to Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs)
On November 15, 2021 – Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), announced the agreement to purchase the IP rights to a novel series of fourth-generation capsid assembly modulators (CAMs) discovered and developed jointly by IRBM, Promidis/CNCCS (a subsidiary of IRBM), Istituto [...]
New breakthrough to help immune systems in the fight against cancer
New research has identified potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity a group of cells which regulate the immune system, which in turn can unleash other immune cells to attack tumours in cancer [...]
“Nucleic acid immunity in gene therapy and disease”
22 January 2020 - h 12.00 Speaker: Anna Kajaste-Rudnitski - Group Leader, Retrovirus-Host Interactions and Innate Immunity to Gene Transfer San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) Host: Lara Manganaro Title: “Nucleic acid immunity in gene therapy and disease”
“How T cells fine-tune their response to infection and cancers”
16 January 2020 - h 12.00 Speaker: Monika Wolkers, Associate Professor at the Dep. of Experimental Immunology, Academic Medical Center and Research Group Leader at Sanquin Research, Dep. of Hematopoiesis – Amsterdam Host: Stefano Biffo Title: “How T cells fine-tune their response to infection and cancers”
“The Matrix connection in Cancer and Immunity”
1 October 2019 - h 12.00 Speaker: Mario Colombo, Director of Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan. Host: Sergio Abrignani Title: "The Matrix connection in Cancer and Immunity"
“Cell-autonomous stress responses in innate immunity and inflammation”
18 July 2019 - h 12.00 Speaker: Evelina Gatti, Research Director, French National Centre for Scientific Research, Marsiglia Host: Raffaele De Francesco Title: “Cell-autonomous stress responses in innate immunity and inflammation”
INGM RESEARCH IS SUPPORTED BY
